Latest Breaking News On - Nucleonics inc - Page 1 : comparemela.com

Ocugen Establishes Vaccine Scientific Advisory Board

Ocugen Establishes Vaccine Scientific Advisory Board
mychesco.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mychesco.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesNorth carolinaSouth africaSan franciscoCatherine pachukDavid fajgenbaumSusan weissSatish chandranHarold varmusBruce forrestShankar musunuriHarvey rubinMike bishopUniversity of californiaUnited biomedical inc

Ocugen Establishes Vaccine Scientific Advisory Board – IT Business Net

Ocugen Establishes Vaccine Scientific Advisory Board – IT Business Net
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesNorth carolinaSouth africaSan franciscoCatherine pachukDavid fajgenbaumSusan weissSatish chandranHarold varmusBruce forrestSanjay subramanianShankar musunuriHarvey rubinMike bishopUniversity of california

Ocugen Establishes Vaccine Scientific Advisory Board

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Ocugen Establishes Vaccine Scientific Advisory Board OcugenDecember 24, 2020 GMT MALVERN, Pa., Dec. 23, 2020 (GLOBE NEWSWIRE) Ocugen, Inc., (NASDAQ: OCGN), a leading biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies, today announced the appointment of a vaccine scientific advisory board comprised of leading academic and industry experts in the vaccine field to evaluate the clinical and regulatory path to approval in the US market of Bharat Biotech’s COVAXIN™, a whole-virion inactivated COVID-19 vaccine candidate to be co-developed by Ocugen and Bharat Biotech for the US market.

New yorkUnited statesNorth carolinaSatish chandranBruce forrestShankar musunuriDavid fajgenbaumVaccines clinical researchOcugen incCastleman disease collaborative networkPenn centerApollon incNucleonics incCytokine storm treatment laboratoryUniversity of pennsylvaniaBharat biotech

Ocugen Establishes Vaccine Scientific Advisory BoardLeading experts to evaluate the clinical and regulatory path to approval in the US market of COVAXIN™, a whole-virion inactivated COVID-19 vaccine

Published: Dec 23, 2020 MALVERN, Pa., Dec. 23, 2020 (GLOBE NEWSWIRE) Ocugen, Inc., (NASDAQ: OCGN), a leading biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies, today announced the appointment of a vaccine scientific advisory board comprised of leading academic and industry experts in the vaccine field to evaluate the clinical and regulatory path to approval in the US market of Bharat Biotech’s COVAXIN™, a whole-virion inactivated COVID-19 vaccine candidate to be co-developed by Ocugen and Bharat Biotech for the US market. Dr. Shankar Musunuri, Chairman, CEO, and Co-Founder of Ocugen remarked, “We are thrilled to welcome this group of esteemed thought leaders to the Ocugen team to assist in our co-development with Bharat Biotech of COVAXIN™. This unique yet traditional vaccine candidate is different from other options currently available in the US market with potentially broader coverage against multip

New yorkUnited statesNorth carolinaSouth africaSan franciscoCatherine pachukDavid fajgenbaumSusan weissLisa descenzaHarold varmusSatish chandranBruce forrestSanjay subramanianShankar musunuriHarvey rubinMike bishop